These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27327580)

  • 1. Current status and future prospects for biologic treatments of psoriasis.
    Cline A; Hill D; Lewallen R; Feldman SR
    Expert Rev Clin Immunol; 2016 Dec; 12(12):1273-1287. PubMed ID: 27327580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in the treatment of psoriasis: role of biologic agents.
    Rich SJ; Bello-Quintero CE
    J Manag Care Pharm; 2004; 10(4):318-25. PubMed ID: 15298530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drugs and treatment targets in psoriasis.
    Kofoed K; Skov L; Zachariae C
    Acta Derm Venereol; 2015 Feb; 95(2):133-9. PubMed ID: 25111317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the mechanisms and efficacy of biological therapies for psoriasis.
    Koo J; Khera P
    J Dermatol Sci; 2005 May; 38(2):75-87. PubMed ID: 15862940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The status of biologic therapies in the treatment of moderate to severe psoriasis.
    Menter A
    Cutis; 2009 Oct; 84(4 Suppl):14-24. PubMed ID: 19916298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
    Alwawi EA; Krulig E; Gordon KB
    Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Small Molecule and Biological Therapeutic Approaches in the Treatment of Psoriasis.
    Turbeville JG; Patel NU; Cardwell LA; Oussedik E; Feldman SR
    Clin Pharmacol Ther; 2017 Jul; 102(1):70-85. PubMed ID: 28317101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapies under development for psoriasis treatment.
    García-Pérez ME; Stevanovic T; Poubelle PE
    Curr Opin Pediatr; 2013 Aug; 25(4):480-7. PubMed ID: 23838833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Side effects of biologic therapies in psoriasis].
    Altenburg A; Augustin M; Zouboulis CC
    Hautarzt; 2018 Apr; 69(4):290-297. PubMed ID: 29568996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic therapy with or without topical treatment in psoriasis: what does the current evidence say?
    Jensen JD; Delcambre MR; Nguyen G; Sami N
    Am J Clin Dermatol; 2014 Oct; 15(5):379-85. PubMed ID: 25027461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of biologics in psoriasis: a review.
    Kim IH; West CE; Kwatra SG; Feldman SR; O'Neill JL
    Am J Clin Dermatol; 2012 Dec; 13(6):365-74. PubMed ID: 22967166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.
    Reich K; Mrowietz U; Radtke MA; Thaci D; Rustenbach SJ; Spehr C; Augustin M
    Arch Dermatol Res; 2015 Dec; 307(10):875-83. PubMed ID: 26358263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of developing TNF-α targeted therapy for the treatment of psoriasis.
    Campa M; Ryan C; Menter A
    Expert Opin Investig Drugs; 2015; 24(10):1343-54. PubMed ID: 26289788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data.
    Rustin MH
    Br J Dermatol; 2012 Nov; 167 Suppl 3():3-11. PubMed ID: 23082810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments for psoriasis and the risk of malignancy.
    Patel RV; Clark LN; Lebwohl M; Weinberg JM
    J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
    Reich K; Burden AD; Eaton JN; Hawkins NS
    Br J Dermatol; 2012 Jan; 166(1):179-88. PubMed ID: 21910698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J; Kerdel F
    Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating moderate to severe psoriasis - best use of biologics.
    Lynch M; Kirby B; Warren RB
    Expert Rev Clin Immunol; 2014 Feb; 10(2):269-79. PubMed ID: 24372444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies.
    Campa M; Menter A
    Expert Opin Investig Drugs; 2016 Nov; 25(11):1337-1344. PubMed ID: 27687859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.